Gain Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Gain Therapeutics stock have an average target of 8.33, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 365.36% from the current stock price of 1.79.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$8.33	$8.00	$12
Change	+235.20%	+365.36%	+346.93%	+570.39%

Analyst Ratings

The average analyst rating for Gain Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	3	3	3	3	3
Buy	2	2	2	2	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+235.20%	Mar 28, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+346.93%	Mar 17, 2025
Louise Chen Scotiabank	Scotiabank	Buy Initiates $12	Buy	Initiates	$12	+570.39%	Mar 7, 2025
Boobalan Pachaiyappan Roth MKM	Roth MKM	Strong Buy Maintains $7	Strong Buy	Maintains	$7	+291.06%	Dec 24, 2024
Boobalan Pachaiyappan Roth MKM	Roth MKM	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+291.06%	Dec 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

40.80K

Revenue Next Year

n/a

from 40.80K

EPS This Year

-0.83

from -0.89

EPS Next Year

-1.23

from -0.83

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	133.93K	132.64K	55.18K	-	40.80K	-	-
Revenue Growth	-	-	-0.96%	-58.40%	-	-	-	-
EPS	-1.33	-1.37	-1.48	-1.71	-0.89	-0.83	-1.23	-1.76
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	210,000	n/a	n/a
Avg	40,800	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.60	-1.06	-1.82
Avg	-0.83	-1.23	-1.76
Low	-1.13	-1.38	-1.70

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.